膈俞穴注射川芎嗪治疗冠心病临床研究  

Clinical Experimental Study on Treatment of Coronary Heart Disease with Injection of Ligustrazine into Geshu Point(BL 17)

作　　者：蔡国伟[1] 梁书忠[2] 

机构地区：[1]同济医科大学附属协和医院针灸科 [2]湖北中医学院针灸骨伤系

出　　处：《中国针灸》1996年第6期3-5,共3页Chinese Acupuncture & Moxibustion

摘　　要：本文对１００例患者分别进行了穴位注射药液及穴位电针刺激，比较观察了其对血浆６－酮－前列腺素Ｆ１α（６－Ｋ－Ｐ）含量、血栓素Ｂ２（ＴＸＢ２）含量和６－Ｋ－Ｐ／ＴＸＢ２比值的影响。结果一疗程后，膈俞川芎嗪组、膈俞生理盐水组、膈俞电针组、肺俞川芎嗪组均能调节血浆６－Ｋ－Ｐ、血浆ＴＸＢ２及６－Ｋ－Ｐ／ＴＸＢ２比值（Ｐ＜０．０１，Ｐ＜０．００１），肺俞电针组无此作用（Ｐ＞０．０５）。进一步的分析表明，有效组间的疗效亦有一定的差异。Effects of acupoint injection and electroacupuncture stimulation on plasma contents of 6-ketoprostaglandin F1α (6-K-P),thromboxane B2(TXB2) and 6-K-P/TXB2 ratio were compared in 100 cases of coronary heart disease. Results showed that after one therapeutic course,plasma contents of 6-K-P and TXB2 and 6-K-P/TXB2 ratio were regulated to varying degrees in Geshu-ligustrazine group,Geshu-saline group, Geshu-electroacupuncture group,Feshu(BL 13)-ligustrazine group.While there was not the effect in Feishu-electroacupuncture group. Among them,the Geshu-ligustrazine group had the best therapeutic effects.The effects are exerted possibly by regulating prostacyclin-thromboxane A2 system.

关 键 词：冠状动脉疾病 川芎嗪 隔俞穴注射 冠心病 

分 类 号：R246.1[医药卫生—针灸推拿学] R259.414[医药卫生—中医临床基础]